Clinical Trials Directory

Trials / Completed

CompletedNCT01914003

Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Prevalence Study (GPS)

A Multi-Center Study of the Prevalence of Known Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Variants and Functional Sucrase Activity by 13C-Sucrose Breath Test in Children With Chronic Diarrhea or Chronic Abdominal Pain

Status
Completed
Phase
Study type
Observational
Enrollment
53 (actual)
Sponsor
QOL Medical, LLC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Congenital sucrose-isomaltase deficiency (CSID) is a rare, genetic disease in which mutations in the sucrose-isomaltase (SI) gene cause digestion problems of sucrose resulting in diarrhea and abdominal pain. Children with chronic, idiopathic diarrhea or abdominal pain will have their sucrose-isomaltase gene assessed for a panel of known CSID mutations to determine the prevalence of these mutations in an enriched population and also determine functional deficiency using a breath test.

Conditions

Timeline

Start date
2013-05-01
Primary completion
2015-05-01
Completion
2015-07-01
First posted
2013-08-01
Last updated
2017-11-06
Results posted
2016-10-10

Locations

19 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01914003. Inclusion in this directory is not an endorsement.

Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Prevalence Study (GPS) (NCT01914003) · Clinical Trials Directory